Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
ISI:FRA
Ionis Pharmaceuticals Inc
€63,58
+0,57%
(+0,36) 1D
30 Apr., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ISI...
Open
€63,58
High
€63,58
Low
€63,58
Mkt. cap
12,44 mjd
Avg. vol.
6,00
Volume
0,00
52-wk high
€72,60
52-wk low
€25,93
No. of employees
1 k
News stories
From sources across the web
Profile
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
About Ionis Pharmaceuticals Inc
CEOBrett P. Monia Ph.D.
Employees1,4 k
Founded1989
HeadquartersCarlsbad, Kalifornië, Verenigde State van Amerika
Sector-
Websiteionis.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
452,05 m
156,72 m
203,33 m
246,00 m
Cost of goods sold
221,61 m
220,09 m
287,60 m
3,00 m
Cost of revenue
221,61 m
220,09 m
287,60 m
3,00 m
Research and development expenses
-
-
-
210,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
90,62 m
96,81 m
130,19 m
151,00 m
Operating expense
90,62 m
96,81 m
130,19 m
361,00 m
Total operating expenses
312,23 m
316,90 m
417,79 m
364,00 m
Operating income
139,82 m
-160,18 m
-214,46 m
-118,00 m
Other non operating income
102,00 k
363,00 k
57,00 k
42,00 m
EBT including unusual items
123,53 m
-128,39 m
-227,92 m
-93,00 m
EBT excluding unusual items
141,84 m
-158,30 m
-212,36 m
-93,00 m
Income tax expense
-20,00 k
213,00 k
1,48 m
-
Effective tax rate
-0,02%
-0,17%
-0,65%
-
Other operating expenses
-
-
-
-
Net income
123,55 m
-128,61 m
-229,39 m
-93,00 m
Net profit margin
27,33%
-82,06%
-112,82%
-37,80%
Earnings per share
0,85
-0,61
-1,15
-0,30
Interest and investment income
24,69 m
23,68 m
24,73 m
-
Interest expense
-22,76 m
-22,16 m
-22,69 m
-17,00 m
Net interest expenses
1,92 m
1,52 m
2,04 m
-17,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
142,68 m
-157,31 m
-210,56 m
-114,89 m
Gain or loss from assets sale
236,00 k
-3,94 m
638,00 k
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer